Arm morbidity after breast-conserving therapy for breast cancer.
This study reports on 110 consecutive patients, mean age 59 years, operated on for partial mastectomy and axillary dissection. Radiotherapy of 50 Gy was administered to 75 of the patients. Most tumours were T1 tumours and all patients were NO. Lymphoedema is defined as an increase in arm volume > 10% and impaired shoulder mobility as an impairment of 15 degrees compared with the preoperative value. After operation, 21 patients developed lymphoedema, 17 in the radiotherapy group and 4 in the group without radiotherapy; 49% of the patients had reduced shoulder mobility, and of these, 57% were in the radiotherapy group and 30% in the group without radiotherapy. We found a good correlation between the number of patients stating arm swelling and patients with registered lymphoedema. There were fewer patients stating limitation of movement than patients with registered impaired mobility; 31% of patients were still perceiving some pain five years after the operation. We conclude, that breast-conserving therapy in breast cancer is afflicted with a significant arm morbidity that persists for several years after surgery.
Tengrup
I
I
Department of Surgery, University Hospital of Malmö, Sweden.
Tennvall-Nittby
L
L
Christiansson
I
I
Laurin
M
M
D000328:Adult; D000368:Aged; D001132:Arm; D001365:Axilla; D001943:Breast Neoplasms / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008207:Lymphatic Metastasis; D008209:Lymphedema / Q000209:etiology*; D015412:Mastectomy, Segmental / Q000009:adverse effects*; D008875:Middle Aged; D009017:Morbidity; D010146:Pain / Q000209:etiology; D011183:Postoperative Complications; D018714:Radiotherapy, Adjuvant / Q000009:adverse effects; D016059:Range of Motion, Articular